Figure-01 (Figure 1)
This is not-available.*
Rosuvastatin Tablet, Film Coated
Product Images NDC 71335-2498
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 71335-2498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-02 (Figure 2)
The text provides data on the comparison between Rosuvastatin 20 mg and Placebo 20 mg in a study with 8901 participants. It includes information on various endpoints such as the primary endpoint (MCE), cardiovascular death, nonfatal stroke, and nonfatal MI. The results show hazard ratios with confidence intervals and p-values for each endpoint, indicating significant differences between the two treatments. Additionally, the study also covers hospitalizations for unstable angina and arterial revascularization. This detailed analysis gives insights into the effectiveness of Rosuvastatin in comparison to a placebo in reducing cardiovascular events.*
Figure-02 (Figure 3)
Label (Lbl713352498)
This text provides information about Rosuvastatin Calcium 40 mg tablets, including the NDC code. It includes a warning to keep the medication out of reach of children and instructions to store at room temperature. The text also mentions the manufacturer and packaging details.*
Structural Formula (Rosuvastatin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
